Prevalence of patients eligible for anti-IL-5 treatment in a cohort of adult-onset asthma

ConclusionsIn a cohort of unselected consecutive patients with adult-onset asthma, 5.9% fulfilled criteria for severe asthma and 2% qualified for anti-IL-5 treatment. Both groups represent a high burden to healthcare and specifically targeted treatment could lead to lower use of healthcare at long-term.
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research